Frontiers in immunology

How DPP-4 inhibitors may help drug-resistant epilepsy through gut bacteria, fatty acids, and hormone signals

Updated

Abstract

Approximately one-third of patients with epilepsy experience drug-resistant epilepsy (DRE).

  • DRE is associated with notable changes in gut microbiota composition.
  • Interventions aimed at modifying the gut microbiota show potential therapeutic benefits.
  • Current pharmacological strategies for specifically targeting gut microbiota in DRE are limited.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

No commercial or financial ties reported.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free